Illumina (ILMN) Rivals Could Catch a Cold From its Warning

Article Stock Quotes (9) Comments (0)

Illumina's (Nasdaq: ILMN) nasty warning after the close could spell trouble for rivals. Shares of ILMN are down 20 percent after saying it sees Q3 sales of about $235 million, which compares to the Street estimate of $277.72 million. The company is also suspending guidance for the full year.

Rivals:
Affymetrix, Inc. (Nasdaq: AFFX)
Agilent Technologies, Inc. (NYSE: A)
Complete Genomics, Inc. (Nasdaq: GNOM)
Life Technologies Corporation (Nasdaq: LIFE)
Luminex Corporation (Nasdaq: LMNX)
Pacific Biosciences of California, Inc. (Nasdaq: PACB)
QIAGEN N.V. (Nasdaq: QGEN)
Sequenom, Inc., (Nasdaq: SQNM)

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Apple (AAPL) Streaming Music Service Could be Delayed - The Verge
• UPDATE: Vanda Pharmaceuticals (VNDA) Opens Higher; Lazard Raises PT to $17
• Marketo (MKTO) IPO Opens 54% Higher

Create E-mail Alert Related Categories

Trader Talk

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?